Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 4/20 | 0.37 |
| ▸ | MAOB | P27338 | 4/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6823277 | 0.91 | PLK1 (0.36) | MAOAMAOBCYP19A1ALDH1A1HPGD | |
| SCHEMBL7835696 | 0.82 | CYP19A1 (0.41) | MAOAMAOBCYP19A1ALDH1A1HPGD | |
| SCHEMBL16591748 | 0.78 | MAOB (0.40) | MAOAMAOBALDH1A1HPGDHSD17B10 | |
| SCHEMBL11617330 | 0.78 | MAOA (0.49) | MAOAMAOBALDH1A1HPGDMAPT | |
| SCHEMBL15856977 | 0.78 | NPC1 (0.47) | ALDH1A1HPGDHSD17B10ESR1MAPT | |
| SCHEMBL6402484 | 0.77 | ALDH1A1 (0.61) | MAOAMAOBALDH1A1KMT2AMAPK1 | |
| SCHEMBL16583152 | 0.73 | ALDH1A1 (0.54) | MAOAMAOBALDH1A1KMT2ANPC1 | |
| SCHEMBL4757846 | 0.73 | ALDH1A1 (0.41) | MAOAMAOBALDH1A1HPGDHSD17B10 | |
| SCHEMBL10587998 | 0.71 | CYP1B1 (0.54) | MAOAMAOBCYP19A1ALDH1A1MAPT | |
| SCHEMBL8746038 | 0.71 | CYP19A1 (0.44) | MAOAMAOBCYP19A1ALDH1A1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1306369-B1 | NOVEL SULFUR COMPOUNDS AND INTERMOLECULAR COMPOUNDS CONTAINING THE SAME AS THE COMPONENT COMPOUND | NIPPON SODA CO (JP) | 2008-11-05 | — | — | EP | disclosed |
| US-6927309-B2 | Sulfur compounds and intermolecular compounds containing the same as the component compounds | NIPPON SODA CO., LTD. (JP) | 2005-08-09 | — | — | US | disclosed |
| US-20040176643-A1 | Novel sulfur compounds and intermolecular compounds containing the same as the component compounds | NIPPON SODA CO., LTD. (JP) | 2004-09-09 | — | — | US | disclosed |
| US-6740782-B2 | SUCH AS CLATHRATE 1,1,2,2-TETRAKIS(4-CHLOROSULFONYL-PHENYL)ETHYLENE; FOR IMPROVED PERFORMANCE DURING SEPARATION OF SUBSTANCES, CHEMICAL STABILIZATION, NON-VOLATILIZATION, SUSTAINED RELEASE, AND PULVERIZATION | NIPPON SODA CO., LTD. (JP) | 2004-05-25 | — | — | US | disclosed |
| US-20030130358-A1 | Such as clathrate 1,1,2,2-tetrakis(4-chlorosulfonyl-phenyl)ethylene; for improved performance during separation of substances, chemical stabilization, non-volatilization, sustained release, and pulverization | NIPPON SODA CO., LTD. (JP) | 2003-07-10 | — | — | US | disclosed |
| EP-1306369-A1 | NOVEL SULFUR COMPOUNDS AND INTERMOLECULAR COMPOUNDS CONTAINING THE SAME AS THE COMPONENT COMPOUND | NIPPON SODA CO., LTD. (JP) | 2003-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176643-A1 | Novel sulfur compounds and intermolecular compounds containing the same as the component compounds | CBS, TST, ABCB7 | MAOA 3956/4885MAOB 3052/4885CYP19A1 3449/4885 |
| US-20030130358-A1 | Such as clathrate 1,1,2,2-tetrakis(4-chlorosulfonyl-phenyl)ethylene; for improved performance during separation of substances, chemical stabilization, non-volatilization, sustained release, and pulverization | CBS, CCT4, TST | MAOA 4649/4885MAOB 4518/4885CYP19A1 3132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.